Literature DB >> 16100291

Increased heme catabolism in critically ill patients: correlation among exhaled carbon monoxide, arterial carboxyhemoglobin, and serum bilirubin IXalpha concentrations.

Hiroshi Morimatsu1, Toru Takahashi, Kyoichiro Maeshima, Kazuyoshi Inoue, Tomoko Kawakami, Hiroko Shimizu, Mamoru Takeuchi, Masataka Yokoyama, Hiroshi Katayama, Kiyoshi Morita.   

Abstract

It has been reported that exhaled carbon monoxide (CO) concentrations and arterial carboxyhemoglobin (CO-Hb) concentration in blood may be increased in critically ill patients. However, there was no study that examined correlation among amount of CO in exhaled air, CO-Hb concentrations in erythrocytes, and bilirubin IXalpha (BR) in serum, i.e., the three major indexes of heme catabolism, within the same subject. Here, we examined CO concentrations in exhaled air, CO-Hb concentrations in arterial blood, and BR levels in serum in 29 critically ill patients. Measurements of exhaled CO, arterial CO-Hb, and serum total BR have been done in the intensive care unit. As control, exhaled CO concentration was also measured in eight healthy volunteers. A median exhaled CO concentration was significantly higher in critically ill patients compared with control. There was significant correlation between CO and CO-Hb and CO and total BR level. We also found CO concentrations correlated with indirect BR but not direct BR. Multivariate linear regression analysis for amount of exhaled CO concentrations also showed significant correlation with CO-Hb and total BR, despite the fact that respiratory variables of study subjects were markedly heterogeneous. We found no correlation among exhaled CO, patients' severity, and degree of inflammation, but we found a strong trend of a higher exhaled CO concentration in survivors than in nonsurvivors. These findings suggest there is an increased heme breakdown in critically ill patients and that exhaled CO concentration, arterial CO-Hb, and serum total BR concentrations may be useful markers in critically ill conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100291     DOI: 10.1152/ajplung.00031.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  14 in total

Review 1.  Use of carbon monoxide as a therapeutic agent: promises and challenges.

Authors:  Roberta Foresti; Mohamed G Bani-Hani; Roberto Motterlini
Journal:  Intensive Care Med       Date:  2008-02-20       Impact factor: 17.440

2.  Changes in arterial oxygen tension correlate with changes in end-expiratory carbon monoxide level.

Authors:  Patrick Schober; Melanie Kalmanowicz; Lothar A Schwarte; Joerg Weimann; Stephan A Loer
Journal:  J Clin Monit Comput       Date:  2007-02-15       Impact factor: 2.502

Review 3.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

4.  Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock.

Authors:  Shoji Takaki; Naoshi Takeyama; Yuka Kajita; Teru Yabuki; Hiroki Noguchi; Yasuo Miki; Yasusuke Inoue; Takashi Nakagawa; Hiroshi Noguchi
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

5.  Effects of inspiratory oxygen concentration on endtidal carbon monoxide concentration.

Authors:  Patrick Schober; Melanie Kalmanowicz; Stephan A Loer
Journal:  J Clin Monit Comput       Date:  2006-03-17       Impact factor: 2.502

6.  Carboxyhemoglobin levels in medical intensive care patients: a retrospective, observational study.

Authors:  Andreas S Fazekas; Marlene Wewalka; Christian Zauner; Georg-Christian Funk
Journal:  Crit Care       Date:  2012-01-11       Impact factor: 9.097

Review 7.  Protective effect of carbon monoxide in transplantation.

Authors:  Atsunori Nakao; Augustine M K Choi; Noriko Murase
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

Review 8.  Pathological Impact of the Interaction of NO and CO with Mitochondria in Critical Care Diseases.

Authors:  J Catharina Duvigneau; Andrey V Kozlov
Journal:  Front Med (Lausanne)       Date:  2017-12-22

Review 9.  Pro-Resolving Molecules-New Approaches to Treat Sepsis?

Authors:  Christa Buechler; Rebekka Pohl; Charalampos Aslanidis
Journal:  Int J Mol Sci       Date:  2017-02-23       Impact factor: 5.923

10.  Elevated carbon monoxide in the exhaled breath of mice during a systemic bacterial infection.

Authors:  Alan G Barbour; Charlotte M Hirsch; Arash Ghalyanchi Langeroudi; Simone Meinardi; Eric R G Lewis; Azadeh Shojaee Estabragh; Donald R Blake
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.